Hepatitis B virus (HBV) has a worldwide distribution and is endemic in many populations.
Due to its unique life cycle which requires an error-prone reverse transcriptase for …

HBV infection in the absence of HBsAg has been a matter of debate for years, but its
existence and clinical relevance are now supported by many publications, editorials and …

Hepatitis B virus (HBV) infection is a major public health problem in many countries, with
nearly 300 million people worldwide carrying HBV chronic infection and over 1 million …

Hepatitis B surface antigen (HBsAg) and Hepatitis B surface antibody (anti-HBs) were
reported simultaneously among Hepatitis B virus (HBV) infections. HBsAg is a specific …

A wide variety of commercial assays is available for the detection of hepatitis B surface
antigen (HBsAg). Clearly, the sensitivity of an assay to detect a variant is dependent on the …

The co-existence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (HBsAb) in
serum of hepatitis B virus (HBV)-chronic carriers has been previously associated with …

The major hydrophilic region (MHR) of hepatitis B surface antigen (HBsAg) harbors
conformational B-cell epitopes and is the major target of neutralizing antibodies to HBsAg …

Amino acid substitutions of hepatitis B surface antigen (HBsAg) may affect the antigenicity
and immunogenicity of HBsAg, leading to immune escape and diagnostic failure. The amino …

Aim: To detect the expression of hepatitis B virus (HBV) genes (HB S and C genes) in early
embryonic cells after introducing motile human sperm carrying HBV DNA into zona‐free …

Mutation in the hepatitis B virus surface antigen (HBsAg) may affect the efficiency of
diagnostic immunoassays or success of vaccinations using HBsAg. Thus, antigenicity and …